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Background: GPR43 is a G-protein-coupled receptor that participates in adipocyte differentiation in mice and is
over-expressed in adipose tissue of obese mice. The aim of this study was to investigate the implication of GPR43
in adipogenesis in humans and to determine the influence of obesity on its expression in human adipose tissue.
Findings: Preadipocytes were isolated from human omental adipose tissue and cultured during 13 days. One
PPARγ agonist (troglitazone) and three GPR43 agonists (two physiological and one synthetic) were tested for their
ability to induce differentiation. After 13 days, the three GPR43 agonists had no impact on aP2 expression, a marker
of adipocyte differentiation, whereas troglitazone led to a huge over-expression of aP2 in these cells but tended to
decrease GPR43 expression (p=0.06).
GPR43 and inflammatory markers expression was also quantified in omental adipose tissue from lean and obese
individuals. GPR43 expression in total adipose tissue was similar between obese patients and lean subjects and did
not correlate with aP2 expression. In contrast, GPR43 expression positively correlated with TNFα mRNA.
Conclusions: Our results suggest the absence of relationship between GPR43 and adipocyte differentiation in
humans, unlike what was observed in mice. Furthermore, GPR43 expression is not increased in adipose tissue from
obese subjects but could be related to TNFα-related inflammatory processes.
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Introduction
GPR43, also known as free fatty acid receptor 2 (FFA2),
is a G-protein-coupled receptor activated by short-chain
fatty acids, i.e. acetate and propionate, produced through
fermentation of non-digestible carbohydrates [1-3]. It is
highly expressed in immune cells but is also present in
other tissues (e.g. adipose tissue, spleen, bone marrow,
intestine, liver) [4] and seems implicated in adipose tis-
sue metabolism. GPR43 activation by acetate and propi-
onate in vitro stimulates adipocyte differentiation in
3T3-L1 preadipocytes. 3T3-L1 cells transfected with
GPR43 siRNA exhibit decreased expression of peroxisome
proliferator-activated receptor gamma (PPARγ) -the
master regulator of adipogenesis- and less fat accumula-
tion [5]. Moreover, acetate and propionate inhibit in vitro* Correspondence: nathalie.delzenne@uclouvain.be
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reproduction in any medium, provided the orand in vivo lipolysis by activating GPR43 [5,6]. In mice fed
a high-fat diet, the augmented adiposity and adipocyte en-
largement have been associated with an over-expression
of PPARγ target genes and GPR43 in subcutaneous adi-
pose tissue. Furthermore, a PPARγ agonist increased
GPR43 expression in explants of mouse subcutaneous adi-
pose tissue thus suggesting PPARγ as a driver of GPR43
expression [7]. Altogether, these results suggest a potential
link between GPR43 expression and adipocyte differenti-
ation in mice. However, in humans, the implication of this
receptor in adipogenesis and its expression in obesity has
not been studied yet.
Methods and materials
Chemicals
All chemicals were purchased from Sigma-Aldrich (Saint
Louis, MO, USA), except the synthetic GPR43 agonist [4-
chloro-α-(1-methyl ethyl)-N-2-thiazolyl-benzeneacetamide]
(CMTB) [8] (Ambinter, Paris, France) and collagenase A
(Roche Diagnostics Belgium, Vilvoorde, Belgium).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adipose tissue
Omental adipose tissue (OAT) from 4 obese patients
undergoing abdominal surgery were fractionated into
adipocytes and stromal-vascular cells (SVC) as previ-
ously described [9,10]. Briefly, fat tissue was cut into
small pieces and incubated for 15 min in a shaking water
bath at 37°C in KREBS-BSA 2% with collagenase A
(8.33 mg/g tissue). Digested tissue was filtered and cen-
trifuged at 400 g for 1 min. The infranatant containing
the SVC was washed three times. Preadipocytes were
grown to confluence in DMEM-F-12 medium (Invitro-
gen, Life Technologies, Gent, Belgium) with 10% fetal
bovine serum (PAA Laboratories, Pasching, Austria),
streptomycin 100 μg/ml and penicillin 100 IU/ml
(Gibco, Inchinnan, Scotland) at 37°C in humidified 5%
CO2 and then differentiated in vitro during 13 days
using a chemically defined serum-free medium consist-
ing of DMEM-F-12 (1:1) supplemented with 15 mM
HEPES, 15 mM NaHC03, 33 μM biotin, 17 μM pantho-
tenate, 10 μg/ml apotransferrin, 66 nM insulin, 1 μM
dexamethasone, 200 pM triiodothyronine, and antibio-
tics. Isobutylmethylxanthine (500 μM) was added during
the first 3 days to induce differentiation. During differen-
tiation, different conditions were tested: control medium
(CT), troglitazone (TZD) (10 μM), acetate (10 μM), pro-
pionate (10 μM) and CMTB (1 μM). DMSO was used to
dilute TZD and CMTB and added to each medium to
obtain the same final concentration (0.13%). Cells were
then harvested and frozen at −80°C until subsequent
mRNA analysis.Isolation of human adipose tissue
OAT was obtained from 10 lean and 23 obese patients
undergoing abdominal surgery after an overnight fast, as
described elsewhere [10]. Descriptive characteristics of
these patients are given in Table 1.Real-time quantitative PCR
Total RNA was isolated using a TriPure Isolation Reagent
Kit (Roche Diagnostics Belgium, Vilvoorde, Belgium),
cDNA was prepared by reverse transcription of 100 ng
total RNA using a Reverse Transcription System Kit
(Promega, Madison, WI, USA) and quantitative PCR was
performed as previously described [7]. Primers used to
detect the targeted genes are available upon request.Table 1 Descriptive characteristics of lean and obese
patients
Men/Women Age (years) BMI (kg/m2)
Lean 4/6 60 ± 4 23.1 ± 0.4
Obese 12/11 42 ± 3 45.1 ± 1.5
Data are mean ± SEM. BMI: body mass index.Statistical analysis
Results are presented as mean ± SEM. Statistical signifi-
cance of difference was assessed by one-way ANOVA
followed by post hoc Tukey’s multiple comparison test
when comparing 3 groups or more, or by a Student t-test
when comparing 2 groups. Correlations were analyzed
using Pearson’s correlation test in GraphPad Prism
(version 5.00 for Windows GraphPad Software, San
Diego, CA, USA). The level of significance was set at
p< 0.05.
Results and discussion
Implication of human GPR43 in adipogenesis
GPR43 is implicated in adipocyte differentiation in mice.
Acetate and propionate, two physiological agonists of
this receptor, induce adipocyte differentiation in 3T3-L1
cells [5]. In vitro and ex vivo experiments also suggest a
link between PPARγ activity, a master regulator of adi-
pogenesis, and GPR43 expression since the incubation
in the presence of a PPARγ agonist induces GPR43 over-
expression in 3T3-L1 adipocytes [5] and explants of
mouse adipose tissue [7]. In this study, we investigated
the influence of GPR43 agonists on adipocyte differenti-
ation in humans. We used preadipocytes isolated from
human OAT. These cells were cultured during 13 days
with different treatments that could potentially induce
differentiation: a PPARγ agonist (TZD), acetate, propion-
ate or one synthetic GPR43 agonist, CMTB. We evalu-
ated the influence of these treatments on the expression
of GPR43 and aP2, a PPARγ target gene known as a late
marker of adipocyte differentiation [11] (Figure 1). TZD
induced an 80-fold increase in aP2 expression thus sign-
ing an important induction of differentiation following
PPARγ activation. Surprisingly, TZD tended to decrease
GPR43 expression (p=0.06). This effect was opposite to
that previously demonstrated in mice [5,7]. Moreover,
the three GPR43 agonists did not significantly modulate
the expression of our genes of interest. These results
allow us to propose that, in humans, GPR43 may not be
implicated in the process of adipogenesis. Indeed, an over-
expression of aP2 -reflecting an increased differentiation-
is not associated with GPR43 over-expression and GPR43
agonists are not able to induce differentiation in human
preadipocytes as demonstrated by the lack of effect on
aP2 expression. These are preliminary results that should
be confirmed, e.g. by showing that blocking GPR43 has no
impact on the TZD-induced differentiation but so far, no
GPR43 antagonist exists.
GPR43 Expression in human adipose tissue: link with
inflammation
Hong et al. reported that GPR43 was over-expressed in
adipose tissue of high-fat diet-fed mice [5]. We demon-
strated that this over-expression was associated with an
Figure 1 Study of GPR43 involvement in human adipogenesis. GPR43 and aP2 mRNA levels in human preadipocytes, 13 days after induction
of differentiation in presence of the vehicle (CT) or different pharmacological agents: troglitazone (TZD), acetate, propionate and CMTB. Mean
value obtained in the CT group (i.e.; medium without the addition of the pharmacological agents) is set at 1. Data are mean ± SEM for 4 different
cultures. Data with different superscript letters are significantly different with p<0.001, according to one-way ANOVA followed by post hoc Tukey’s
multiple comparison test. GPR43: G-protein-coupled receptor 43.
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flammatory markers [7]. However, so far, GPR43 expres-
sion has never been evaluated in adipose tissue of obese
humans. Therefore, in human OAT collected from 10 lean
and 23 obese patients, we investigated the expression of
GPR43 but also aP2, TNFα, CD68 and MCP-1 mRNAs
as markers of adipocyte differentiation, inflammation,Figure 2 Influence of obesity on GPR43 expression in human adipose
omental adipose tissue collected from 10 lean patients and 23 obese patie
B. Correlations between GPR43 mRNA and TNFα, CD68 and MCP-1 mRNAs
G-protein-coupled receptor 43; TNFα: tumor necrosis factor α; CD68: clustemacrophages and inflammatory cells recruitment, re-
spectively [12,13] (Figure 2A). In comparison to lean sub-
jects, obese patients exhibited no significant increase in
GPR43 expression, despite an important variability, and a
significant over-expression of CD68, thus suggesting a
higher macrophages content, a well-established charac-
teristic of obese adipose tissue [14]. On the other hand,tissue. A. GPR43, aP2, TNFα, CD68 and MCP-1 mRNA levels in human
nts. Data are mean ± SEM, * p<0.01 according to the Student’s t-test.
, r and p values according to the Pearson’s correlation test. GPR43:
r of differentiation 68; MCP-1: monocyte chemoattractant protein-1.
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modified in obese subjects compared to lean individuals.
Interestingly, there was no correlation between GPR43
mRNA and aP2 mRNA (Pearson r = −0.10, p = 0.61) thus
strengthening our hypothesis on the absence of link be-
tween these two genes in human adipose tissue. In con-
trast, we observed significant and positive correlations
between GPR43 mRNA on one hand and CD68, TNFα
and MCP-1 expression on the other hand (Figure 2B).
However, it is worth noting that, when removing the 3
obese patients with the highest GPR43 expression (out-
liers), the sole correlation remaining significant was
between GPR43 and TNFα mRNAs (Pearson r = 0.57,
p = 0.003). Thus, unlike what has been observed in
mice, human obesity is not associated with an over-
expression of GPR43 in OAT. This receptor may not
be implicated in adipogenesis but would rather be
linked to inflammatory processes in adipose tissue, as
suggested by the strong correlation between GPR43
and TNFα mRNAs. Interestingly, a link between
GPR43 and inflammation has already been proposed in
some inflammatory diseases [15]. In models of colitis,
arthritis and asthma, Maslowski et al. highlighted an
exacerbated inflammation in GPR43-deficient mice as
compared to wild-type mice, thus suggesting a benefi-
cial role of GPR43 in these inflammatory processes
[16]. However, another study showed that GPR43
knockout mice were protected against chronic Dextran
Sulfate Sodium-induced colitis thus proposing the op-
posite conclusion [17]. Therefore, the beneficial or
deleterious implication of GPR43 in inflammation is
still controversial and our preliminary results suggest
adipose tissue as a new potential target to focus on
when studying GPR43 and inflammation in humans.
Conclusion
In this first study focusing on GPR43 in human adipose
tissue, some data previously shown in mice, i.e. the im-
plication of GPR43 in the process of adipocyte differenti-
ation, have not been confirmed. Indeed, GPR43 does not
seem implicated in human adipogenesis as its ligands do
not induce differentiation of preadipocytes. Moreover,
GPR43 expression is not induced by a PPARγ agonist
and is not correlated to aP2 expression, a well-known
marker of adipocyte differentiation. However, although
GPR43 is not over-expressed in the OAT of all obese
individuals, its expression seems associated with TNFα-
related inflammatory process. Larger studies are needed
in order to evaluate the co-regulation of GPR43 and
TNFα expression in human adipose tissue.
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